| Logo | Name | Σ |
|---|---|---|
 | CEVA SANTE ANIMALE Together, beyond animal health. Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our … Sectors: Animal Health Pharmaceutical | 341 |
 | bioMérieux Pioneering Diagnostics A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety. in vitro … Sectors: Biotechnology | 468 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3678 |
 | Le Figaro Le Figaro, the culture of freedom since 1826, 1st generalist daily and 1st information site most consulted in France. Displaying an audience of more than 9 million unique visitors (Source: Mediamétrie/Netraings), the site is characterized by the quality and depth of its content, the fruit of complementarity between its paper editors (daily and magazines) and its web writing; By its Internet 2.0 uses and the importance of video which has become a central element of the content supply. Lefigaro.fr also supports its development on the synergies built with the other sites of the Figaro group (Figaro Classifields, Meteoconsult, the Individual, … Sectors: Media | 4115 |
 | CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: Research | 3471 |
 | ONLYLYON Agir ici. Changer demain. ONLYLYON is both the brand and the international marketing programme created in 2007 by the 13 institutional partners across the Lyon area who share the same objective: to strengthen the reputation and competitiveness of Lyon in a context of growing competition between world cities in attracting talent, companies, projects and tourists. This initiative brings together 24 public and private partners. The ONLYLYON initiative is wide-ranging, both in terms of its fields of application (sectors, markets) and the kinds of activities it carries out (communications, press relations, ambassador networks, digital strategy, etc.), its mission being to promote … Sectors: National and local authorities | 371 |
 | CCI de région Auvergne-Rhône-Alpes The CCIs of Auvergne-Rhône-Alpes, 360 ° solutions for companies and territories! The CCIs, the 1st public economic network of #Proximity! 🔵 👉🏻 Facilitate your #successes is our job! 👉🏻 In Auvergne-Rhône-Alpes, the Region CCI supervises and supports the activities of the 13 Territorial CCIs: - Support and represent the 400,000 companies in the trade, industry and services in the region 🤝 - contribute to economic development and territorial planning in the region 💡 How ? Thanks to the mobilization of 500 elected officials and 1,500 employees #proximity 👌🏻 Permanent interlocutors of companies for all their daily or strategic concerns, the … Sectors: Chamber of commerce | 436 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 507 |
 | Région Auvergne-Rhône-Alpes #Auvergnerhonealpes Auvergne-Rhône-Alpes is a large region that has many advantages: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th region most populated in Europe - covering nearly 70,000 km2, or 13 % of the metropolitan territory, its area is equivalent to that of Ireland. - In France, it is the first industrial and gastronomic region, it ranks first for agricultural productions under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe with a … Sectors: National and local authorities | 4466 |
 | GENEO Capital Entrepreneur When we invest, we invest ourselves 👉 The raison d'être of Geneo, inscribed in its statutes, is to put at the service of the real economy a positive finance, that is to say: • Long -term finance, capable of passing cycles, adapting to the natural cycle of each company • A finance that focuses on the increase in human capital as the main lever for creating the value and sustainability of companies and their growth. The one that relies on experience, the desire, the commitment of all generations of entrepreneurs to accelerate, in a powerful collective. • A finance that … | 293 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 938 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 54,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1965 |
 | CEA The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and … Sectors: Research | 2885 |
 | Ministry of Economy Within the ministry, more than 135,000 agents today put their talent at the service of a strong and sustainable economy in the region and in Paris. Service for users, legal affairs, economic development, performance management ... More than 160 professions are exercised in the administrations of Bercy. The diversity of these activity sectors makes it possible to build rich career paths adapted to everyone's profiles. How to join the services of Bercy? Each year, the ministry recruits 5,000 women and men. Many competitions of all levels are organized. Recruitment procedures without competition also exist, for disabled workers and young people … | 3234 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1488 |